"10.1371_journal.pone.0025974","plos one","2011-10-19T00:00:00Z","Jill L Schwartz; Wes Rountree; Angela D M Kashuba; Vivian Brache; Mitchell D Creinin; Alfred Poindexter; Brian P Kearney","CONRAD, Eastern Virginia Medical School (EVMS), Arlington, Virginia, United States of America; Family Health International (FHI), Research Triangle Park, North Carolina, United States of America; University of North Carolina Eshelman School of Pharmacy and University of North Carolina CFAR Clinical Pharmacology and Analytical Chemistry Core Laboratory, University of North Carolina, Chapel Hill, North Carolina, United States of America; PROFAMILIA, Santo Domingo, Dominican Republic; Center for Family Planning Research, University of Pittsburgh and Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America; Advances in Health, Inc., Houston, Texas, United States of America; Gilead Sciences, Foster City, California, United States of America","Analyzed the data: WR ADMK JLS BPK. Wrote the paper: JLS WR ADMK. Conceived and designed the experiments: JLS WR ADMK VB MDC AP BPK along with the Tenofovir Gel Development Team. Performed the clinical experiments: VB MDC AP. Performed the laboratory experiments: ADMK BPK.","Brian Kearney works for Gilead, Inc. which manufactures Viread√ª. Jill Schwartz works for CONRAD, a nonprofit that supplies tenofovir gel. Alfred Poindexter is the Medical Director of Advances in Health, Inc. and has no competing interests.  The declared affiliations do not alter the authors' adherence to PLoS ONE policies on sharing data and materials.","2011","10","Jill L Schwartz","JLS",7,FALSE,12,3,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
